CS_Logo.png

Predicting Deterioration - Saving Lives.

  • Home

  • Technology

    • Publications
  • Team

  • News

  • Contact

  • More

    Use tab to navigate through the menu items.
    • LinkedIn
    • Twitter

    Our Recent Posts

    Cardiovascular Reserve Index (CVRI) calculator receives a CE Mark approval

    Maoz Ben-Ari, CardioScale CEO Interviewed in MedTalk

    Come see us @ MEDinIsrael2019

    Come see us @ MEDinIsrael2019

    Archive

    • October 2019
    • April 2019
    • March 2019
    • November 2018
    • October 2018
    • August 2018
    • July 2018
    • June 2018
    • March 2018
    • February 2018
    • May 2017
    • April 2017
    • May 2016

    Tags

    • Audience Engagement
    • Blog
    CardioScale Wins CTTSC3

    CardioScale Wins CTTSC3

    CardioScale Wins The Combating Terrorism Technology StartUp Challange (CTTSC3) Presented by The US Department of Defence (CTTSO), Israel...

    Australian Patent Aproved

    CardioScale Ltd. announces that the application for its proprietary CVRI Index has been approved by the Australian Authority IP...

    CardioScale Patents CVRI in Asian Markets

    CardioScale Ltd. Announces that its proprietary CVRI Index has been approved by both the Chinese and Japanese Patent Authorities, giving...
    China Patent Granted.

    China Patent Granted.

    CardioScale announced today that its Patent in Mainland China had successfully passed examination and was fully granted. The company...
    CardioScale announces U.S patent Granted

    CardioScale announces U.S patent Granted

    The company specializing in early detection of hemodynamic deterioration based on its innovative technology announced today that the U.S....

    Meet us at IEICI – Emergency Medicine in Paris, France | 24 – 25 April, 2017

    Innovation in Emergency Medicine, Preparedness, Management & Rehabilitation. Paris – France | 24 – 25 April, 2017 Sharing the best...
    CardioScale has been selected to participate in a Global Startup Program in Taipei – Taiwan | May 22

    CardioScale has been selected to participate in a Global Startup Program in Taipei – Taiwan | May 22

    Taiwan is a country with advanced medical technology, high-efficient infrastructure, and potential aging markets nearby. In 2016...
    CardioScale selected to present at the ESICM International Congress for Intensive Care Medicine in V

    CardioScale selected to present at the ESICM International Congress for Intensive Care Medicine in V

    We are delighted to inform that CardioScale's abstract has been selected by the Congress Scientific Committee to present its studies: ...
    12
    3

    ©2018 by CardioScale Ltd.. Proudly created with Wix.com